Masimo Corp (NASDAQ:MASI)
| 218.02 Delayed Data As of Jan 21 |  -3.64 / -1.64%Today’s Change | 205.10 Today|||52-Week Range 305.21 | -25.53% Year-to-Date |
Latest MASI News | Press Releases
| 3 Profitable Businesses With Solid Financial Conditions Jan 21 / GuruFocus News - Paid Partner Content | Masimo (MASI) Provides FY22 View, Preliminary FY21 Results Solid Jan 13 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 221.66 |
| Today’s open | 221.50 |
| Day’s range | 217.76 - 225.11 |
| Volume | 14,302 |
| Average volume (3 months) | 260,052 |
| Market cap | $12.1B |
Data as of 4:00pm ET, 01/21/2022
Growth & Valuation
| Earnings growth (last year) | +19.63% |
| Earnings growth (this year) | +7.99% |
| Earnings growth (next 5 years) | +1.30% |
| Revenue growth (last year) | +21.96% |
| P/E ratio | 54.2 |
| Price/Sales | 13.62 |
| Price/Book | 8.59 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TNDMTandem Diabetes Care... | -0.43 | -0.35% |
| ---- | ||
| NVCRNovocure Ltd | -2.92 | -4.17% |
| LIVNLivaNova PLC | -3.25 | -3.97% |
Data as of 4:00pm ET, 01/21/2022
Financials
| Next reporting date | February 16, 2022 |
| EPS forecast (this quarter) | $1.11 |
| Annual revenue (last year) | $1.1B |
| Annual profit (last year) | $240.3M |
| Net profit margin | 21.01% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Irvine, California |
Forecasts
